FDA: Recalled Microdosing Candies Linked to Reports of Illness Still on Shelves

The agency did not say in which states or stores the products are still available, but noted it is ’monitoring the firm’s recall to assess its effectiveness.’

The U.S. Food and Drug Administration is investigating Diamond-Shruumz Microdosing candy bars after hospitalizations were reported. Courtesy of the FDA

The Food and Drug Administration (FDA) warned this week that several stores are still selling previously recalled mushroom-infused products from the brand Diamond Shruumz.

On July 16, the FDA said in an update posted to its website that the recalled “microdosing” candies laced with a chemical found in mushrooms “are still on the shelves at several smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC).”